We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

132 hedge funds and large institutions have $494M invested in Lakefront Biotherapeutics American Depositary Shares in 2021 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 49 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

96% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 25

85% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 20

14% more funds holding

Funds holding: 116 → 132 (+16)

9% more capital invested

Capital invested by funds: $452M → $494M (+$41.4M)

2.8% more ownership

Funds ownership: 6.98% → 9.78% (+2.8%)

50% less call options, than puts

Call options by funds: $31.4M | Put options by funds: $62.9M

Holders
132
Holders Change
+16
Holders Change %
+13.79%
% of All Funds
2.32%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.05%
New
37
Increased
49
Reduced
25
Closed
20
Calls
$31.4M
Puts
$62.9M
Net Calls
-$31.5M
Net Calls Change
-$874K

Top Buyers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
+$53.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$22.2M
3
O
OrbiMed
New York
+$21.3M
4
Goldman Sachs
Goldman Sachs
New York
+$20.8M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$19M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$22.8M
2
EAM
Eventide Asset Management
Massachusetts
-$11.1M
3
Citigroup
Citigroup
New York
-$9.21M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$7.43M
5
Renaissance Technologies
Renaissance Technologies
New York
-$5.92M
Name Holding Trade Value Shares
Change 		Change in
Stake
Group One Trading
26
Group One Trading
Illinois
$3.05M +$3.61M +39,187 +11,228%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$2.89M +$323K +3,508 +10%
HJIM
28
Henry James International Management
New York
$2.73M +$1.49M +16,190 +84%
HM
29
HealthCor Management
New York
$2.64M +$3.16M +34,260 New
E
30
Ergoteles
New York
$2.52M +$3.01M +32,654 New
PPA
31
Parametric Portfolio Associates
Washington
$2.22M +$581K +6,306 +28%
Envestnet Asset Management
32
Envestnet Asset Management
Illinois
$1.92M -$839K -9,106 -27%
BFM
33
Boothbay Fund Management
New York
$1.9M +$2.27M +24,674 New
SIS
34
Susquehanna International Securities
Ireland
$1.67M – – –
FIM
35
Freedom Investment Management
Connecticut
$1.6M +$123K +1,334 +7%
CII
36
Capital International Inc
California
$1.56M -$59.6K -647 -3%
CG
37
Cutler Group
California
$1.51M +$1.64M +17,850 +992%
Capital Fund Management (CFM)
38
Capital Fund Management (CFM)
France
$1.48M +$1.77M +19,223 New
Bank of America
39
Bank of America
North Carolina
$1.39M +$511K +5,551 +44%
Nomura Asset Management
40
Nomura Asset Management
Japan
$1.33M +$811K +8,800 +105%
AA
41
AlphaCentric Advisors
Puerto Rico
$1.31M +$1.34M +14,600 +608%
Jane Street
42
Jane Street
New York
$1.31M -$2.52M -27,392 -62%
CSS
43
Cubist Systematic Strategies
Connecticut
$1.27M +$163K +1,773 +12%
Acadian Asset Management
44
Acadian Asset Management
Massachusetts
$1.09M +$1.3M +14,087 New
US Bancorp
45
US Bancorp
Minnesota
$1.08M +$1.26M +13,702 +3,871%
Stifel Financial
46
Stifel Financial
Missouri
$968K +$33.8K +367 +3%
AAA
47
Affinity Asset Advisors
New York
$964K +$1.15M +12,500 New
HF
48
HRT Financial
New York
$886K +$1.06M +11,494 New
BBA
49
Baker Bros. Advisors
New York
$862K – – –
Renaissance Technologies
50
Renaissance Technologies
New York
$825K -$5.92M -64,210 -86%
1
2
3 4 5

LKFT Hedge Fund Activity: Q1 2021 in Review

132 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q1 2021, worth a combined $494M — up 9.2% from $452M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new LKFT positions and 20 closed out — a net gain of 17 holders — while 49 added to existing stakes and 25 trimmed.

The largest buyer was Capital International Investors, adding an estimated $53.8M. The largest seller was BlackRock, cutting an estimated $22.8M.

  • 132 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q1 2021, up from 116 in Q4 2020.
  • Funds reported $494M of Lakefront Biotherapeutics American Depositary Shares stock for Q1 2021, up 9.2% quarter-over-quarter.
  • 37 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q1 2021 and 20 closed out, a net change of +17 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q1 2021 was Capital International Investors, an estimated $53.8M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q1 2021 was BlackRock, an estimated $22.8M sold.

Based on aggregated 13F filings for Q1 2021.